|

177Lu-Dotatate Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: Lu oxodotreotide, Lutathera®, ¹⁷⁷Lu-DOTA0-TATE

Other1 trial

177Lu-DOTATATE for Recurrent Meningioma
Phase 2

Chicago, Illinois1 trial

Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

University of Chicago Medicine Comprehensive Cancer Center

Phase 1

Madison, Wisconsin1 trial

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

University of Wisconsin - Madison

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.